Skip to main content
Top
Published in: Rheumatology International 12/2009

01-10-2009 | Short Communication

Identification of candidate genes for susceptibility to reactive arthritis

Authors: Markus Rihl, Christian Barthel, Andreas Klos, Reinhold E. Schmidt, Paul P. Tak, Henning Zeidler, Jens G. Kuipers

Published in: Rheumatology International | Issue 12/2009

Login to get access

Abstract

This study was undertaken to evaluate the gene expression profile in monocytes from three patients with reactive arthritis (ReA) in remission in order to identify candidate genes accounting for a potential susceptibility to ReA. Gene expression analyses revealed eight differentially expressed mRNA transcripts in monocytes of ReA patients. The major part of genes encoded cytokines, growth factors and chemokines. There was a remarkably high proportion of proangiogenic factors, in particular IP10, ENA-78, and IL-8 accounting for a genetically determined susceptibility to ReA at the host cell level.
Literature
4.
5.
go back to reference Sieper J, Rudwaleit M, Braun J, van der Heijde D (2002) Diagnosing reactive arthritis: role of clinical setting in the value of serologic and microbiologic assays. Arthritis Rheum 46:319–327. doi:10.1002/art.504 PubMedCrossRef Sieper J, Rudwaleit M, Braun J, van der Heijde D (2002) Diagnosing reactive arthritis: role of clinical setting in the value of serologic and microbiologic assays. Arthritis Rheum 46:319–327. doi:10.​1002/​art.​504 PubMedCrossRef
6.
7.
go back to reference Gu J, Rihl M, Märker-Hermann E et al (2002) Clues to pathogenesis of spondyloarthropathy derived from synovial fluid mononuclear cell gene expression profiles. J Rheumatol 29:2159–2164PubMed Gu J, Rihl M, Märker-Hermann E et al (2002) Clues to pathogenesis of spondyloarthropathy derived from synovial fluid mononuclear cell gene expression profiles. J Rheumatol 29:2159–2164PubMed
8.
go back to reference Rihl M, Baeten D, Seta N et al (2004) Technical validation of cDNA-based microarray as screening technique to identify candidate genes in synovial tissue biopsies from spondyloarthropathy patients. Ann Rheum Dis 63:498–507. doi:10.1136/ard.2003.008052 PubMedCrossRef Rihl M, Baeten D, Seta N et al (2004) Technical validation of cDNA-based microarray as screening technique to identify candidate genes in synovial tissue biopsies from spondyloarthropathy patients. Ann Rheum Dis 63:498–507. doi:10.​1136/​ard.​2003.​008052 PubMedCrossRef
9.
go back to reference Rihl M, Gu J, Baeten D, Märker-Hermann E et al (2004) Alpha beta but not gamma delta T cell clones in synovial fluids of patients with reactive arthritis show active transcription of tumour necrosis factor alpha and interferon gamma. Ann Rheum Dis 63:1673–1676. doi:10.1136/ard.2003.018192 PubMedCrossRef Rihl M, Gu J, Baeten D, Märker-Hermann E et al (2004) Alpha beta but not gamma delta T cell clones in synovial fluids of patients with reactive arthritis show active transcription of tumour necrosis factor alpha and interferon gamma. Ann Rheum Dis 63:1673–1676. doi:10.​1136/​ard.​2003.​018192 PubMedCrossRef
10.
go back to reference Koch AE, Kunkel SL, Harlow LA et al (1994) Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis. J Clin Invest 94:1012–1018. doi:10.1172/JCI117414 PubMedCrossRef Koch AE, Kunkel SL, Harlow LA et al (1994) Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis. J Clin Invest 94:1012–1018. doi:10.​1172/​JCI117414 PubMedCrossRef
12.
go back to reference O’Sullivan BJ, Thomas HE, Pai S et al (2006) IL-1 beta breaks tolerance through expansion of CD25+ effector T cells. J Immunol 176:7278–7287PubMed O’Sullivan BJ, Thomas HE, Pai S et al (2006) IL-1 beta breaks tolerance through expansion of CD25+ effector T cells. J Immunol 176:7278–7287PubMed
Metadata
Title
Identification of candidate genes for susceptibility to reactive arthritis
Authors
Markus Rihl
Christian Barthel
Andreas Klos
Reinhold E. Schmidt
Paul P. Tak
Henning Zeidler
Jens G. Kuipers
Publication date
01-10-2009
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 12/2009
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-0992-6

Other articles of this Issue 12/2009

Rheumatology International 12/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.